Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
The Director, HCP Marketing - DMD leads the development and execution of HCP-focused strategies and initiatives that empower care providers who treat Duchenne Muscular Dystrophy. The role involves driving impactful HCP engagement programs that support successful market entry and long-term adoption, and requires strategic vision with hands-on execution, ensuring Dyne delivers meaningful engagement and education aligned with our mission and brand objectives.
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
Dyne Therapeutics